GlassScriptPhysician profile
Clint D Mower
NPI 1437653854
$41,347.12
in general payments reported to CMS, 2019-2025
50 companies · $9,610 in 2025
The $9,610 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.95 · 2022: $1,273 · 2023: $16K · 2024: $14K · 2025: $9,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $5,189 · Food and Beverage: $4,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,245.00 |
| Travel and Lodging | $5,189.07 |
| Food and Beverage | $4,560.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37,073.08 | 2022-2025 | Spravato, Xarelto |
| Abbvie INC. | $1,228.94 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $217.69 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $199.44 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Corcept Therapeutics | $172.68 | 2022-2024 | Korlym |
| Novo Nordisk INC | $172.02 | 2021-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.23 | 2022-2025 | Jardiance |
| Corium, LLC | $168.92 | 2022-2025 | Azstarys |
| Tris Pharma INC | $151.09 | 2022-2025 | Dyanavel Xr |
| Amgen INC. | $143.72 | 2022-2025 | Otezla, Repatha, Prolia |
| Axsome Therapeutics, INC. | $129.53 | 2024-2025 | Auvelity, Sunosi |
| Lucid Diagnostics INC. | $107.11 | 2023 | |
| Dynavax Technologies Corporation | $101.91 | 2022 | |
| Pfizer INC. | $92.82 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $90.11 | 2022-2023 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clint Mower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.